DOCSLIB.ORG

A Recovered Case of Massive Pericardial Effusion with Impending Cardiac Tamponade: an Atypical Presentation of COVID-19

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
A Recovered Case of Massive Pericardial Effusion with Impending Cardiac Tamponade: an Atypical Presentation of COVID-19 Mozumder NEE, et al., Archiv Surg S Educ 2021, 3: 013 DOI: 10.24966/ASSE-3126/100013 HSOA Archives of Surgery and Surgical Education Case Report 2019 (COVID-19) has become a global health emergency due to its A Recovered Case of high infectivity along with significant morbidity and mortality [1,2]. According to the Johns Hopkins COVID-19 resource center, more Massive Pericardial Effusion than 14 million people have been infected with this virus worldwide with more than six hundred thousand mortality confirmed up to 20 with Impending Cardiac July, 2020 [3]. Though fever, cough, myalgia and shortness of breath have been considered as common symptoms, patient may develop Tamponade: An Atypical serious complications like Acute Respiratory Distress Syndrome (ARDS), cardiac injury and secondary super infection, which can Presentation of COVID-19 lead to death [4]. Substantial number of COVID-19 patients have been presented with acute coronary syndrome (STEMI or NSTEMI), acute myocardial injury without obstructive coronary artery disease, Noor-E-Elahi Mozumder1*, Muhammad Nasif Imtiaz1, Omar Sadeque Khan1, Rezwanul Hoque1, Khan Amanur Rahman1, Abu arrhythmias, heart failure ± cardiogenic shock, pericardial effusion, Jafar Tareq Morshed2, Zanzibul Tareq2 thromboembolic complications, which have been termed as acute COVID-19 Cardiovascular Syndrome (ACovCS) [5]. In this context, 1Department of Cardiac Surgery, Bangabandhu Sheikh Mujib Medical University, we are reporting a case of COVID-19 complicated with massive Dhaka, Bangladesh pericardial effusion with impending cardiac tamponade and we have 2Department of Cardiac Surgery, National Institute of Cardiovascular Disease, found that no such massive effusion case has been reported yet. Sher-E-Bangla Nagar, Dhaka, Bangladesh Case Report A 54 year old hypertensive, type-2 diabetic woman presented to the emergency department with orthopnea, dyspnea, fever, cough, Background myalgia, nausea, anorexia for 6 days. Three members of her family COVID-19 became a global health emergency due to its highly was suffering from fever and 1 day back her son tested positive for contagious nature. A substantial number of patients have been SARS-CoV-2. On physical examination, she was found anxious, presented in emergency with acute COVID-19 Cardiovascular febrile (100°C), dyspneic (aggravates on lying down). Her oxygen Syndrome (ACovCS). Pericardial involvement has been reported saturation was 98%, respiratory rate 32 breaths/min, heart rate rarely so far. We report a case of massive pericardial effusion with 122bpm, pulse was feeble, pulsus paradoxus present and heart sound impending cardiac tamponade in a COVID-19 patient. Pericardial fluid was muffled. She also had raised JVP, diminished breath sound in left drainage done urgently using CV catheter under echocardiographic lower lung field, bilateral leg edema. Admission ECG showed sinus guidance and 1000ml of sero-hemorrhagic fluid drained. Thorough tachycardia with low voltage ECG wave. After initial management, investigation revealed cytokine storm and no other apparent cause her nasopharyngeal swab was sent for RT-PCR of SARS-CoV-2 and of pericardial effusion. Critical clinical evaluation of cardiovascular CT scan of chest was done which revealed pericardial effusion and system of patients with COVID-19 is essential to save lives. collapse of left lower lung (Figure 1). Introduction Since its emergence in Wuhan, China, a novel coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has affected almost every country of the world. Coronavirus disease *Corresponding author: Noor-E-Elahi Mozumder, Department of Cardiac Surgery, Bangabandhu Sheikh Mujib Medical University, Shahbag, Dhaka, Bangladesh, Tel: +880 1813750616; E-mail: [email protected] Citation: Mozumder NEE, Imtiaz MN, Khan OS, Hoque R, Rahman KA, et al. (2021) A Recovered Case of Massive Pericardial Effusion with Impending Cardiac Tamponade: An Atypical Presentation of COVID-19. Archiv Surg S Educ 3: 013. Received: February 24, 2021; Accepted: March 01, 2021; Published: March 10, 2021 Copyright: © 2021 Mozumder NEE, et al. This is an open-access article dis- tributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided Figure 1: CT scan of chest. the original author and source are credited. Citation: Mozumder NEE, Imtiaz MN, Khan OS, Hoque R, Rahman KA, et al. (2021) A Recovered Case of Massive Pericardial Effusion with Impending Cardiac Tamponade: An Atypical Presentation of COVID-19. Archiv Surg S Educ 3: 013. • Page 2 of 6 • She was found RT-PCR positive for SARS-CoV-2 and emergency complications and it is a leading cause of death in COVID-19 [7- echocardiography revealed severe circumferential pericardial 10]. Among acute COVID-19 cardiovascular syndromes, acute effusion (30mm) with partial collapse of right atrium. Patient was coronary syndrome and myocardial injury are reported commonly immediately taken to operating room for pericardial fluid drainage. and pericardial involvement has been reported rarely. A meta-analysis On operating table her blood pressure was 80/40mm Hg, pulse- 130 of chest CT findings of 2738 COVID-19 patients reported pericardial beats/min, SpO2- 92% without oxygen and there was arrhythmia effusion in 4.55% of patients [11]. We have found 4 reported cases on ECG. Immediate pericardial fluid drainage done in minimal of cardiac tamponade with COVID-19. Among them 3 patients had invasive way using CV catheter in seldinger technique under preexisting cardiac disease (cardiomyopathy and myopericarditis) echocardiographic guidance from subcostal approach and 1000ml and 1 patient developed mechanical ventilation associated tamponade of sero-hemorrhagic fluid was drained. Pericardial fluid was sent [12-15]. We are reporting the case of impending cardiac tamponade for physical, biochemical, cytological and microbiological study. due to massive sero-hemorrhagic pericardial effusion with COVID-19, Patient’s clinical condition improved significantly after drainage of which we urgently drained in minimal invasive way using CV pericardial fluid. Continuous pericardial drainage was maintained by catheter in seldinger technique under echocardiographic guidance. CV catheter in situ for 72 hours and a total of 1250ml of fluid was Patient also had cytokine release syndrome as reflected by raised drained. Pericardial fluid study revealed no malignant cell, negative ESR, CRP, D-Dimer, Ferritin, LDH and lymphopenia. The patient for Gram stain and acid-fast bacilli smear, no growth on bacterial and had no previous history of angina, myocarditis or cardiac injury fungal culture, WBC- 700/mm3 (polymorph- 95%, lymphocyte- 5%), which was demonstrated by normal troponin-I level, no regional wall glucose- 3.41mmol/L, protein- 29.76g/L. RT-PCR of pericardial fluid motion abnormality and good ejection fraction on echocardiography. couldn’t be done due to lack of facility. Thyroid function test and Pericardial effusion is a common manifestation of viral pericarditis serum albumin was normal. After 72 hours chest x-ray revealed no which can lead to cardiac tamponade, but such massive effusion is effusion and ECG revealed anterior ischemia (T wave inversion in rare. Exact mechanism of cardiac involvement of COVID-19 hasn’t lead V1-V6). Abnormal laboratory test findings were ESR- 69mm in been understood yet, but it has been hypothesized that direct viral 1st hour, CRP- 48mg/l, D-Dimer- 9.8mg/l, NT-pro BNP- 1423pg/ml invasion or autoimmune type reaction leading to cytokine storm and and Ferritin- 880.2ng/ml which reflects about cytokine storm in body. exaggerated systemic inflammatory response may be responsible [13-16]. However, direct mechanism of pericarditis and pericardial Patient was treated with broad spectrum antibiotics, methyl effusion due to COVID-19 is still unclear. So far, only one case prednisolone, diuretics, ACEI, beta blocker, LMWH and other has been reported RT-PCR positive of pericardial fluid with several supportive management for COVID-19. She became afebrile after 7 false negative results [14,17]. Thus, RT-PCR of pericardial fluid in days and found RT-PCR negative for COVID-19 after 12 days. She case of pericardial effusion is conclusory for COVID-19, clinical was discharged as her clinical condition improved overall. She came correlation needed rather and CV catheter can be used for emergency to follow-up after 2 weeks and routine investigations including ECG, pericardiocentesis in impending cardiac tamponade, especially in this Echocardiography were done. T inversion was no longer present pandemic situation. on chest leads of ECG and Echocardiography showed good left ventricular function (EF-67%), no regional wall motion abnormality Conclusion and minimal (2mm) posterior effusion (Figure 2). Other routine tests Critical clinical evaluation of cardiovascular system of every revealed normal finding. COVID-19 patient in emergency department is necessary. Quick anticipation and timely intervention can save lives during this pandemic. References 1. Wu Z, McGoogan JM (2020) Characteristics of and important lessons from the Coronavirus Disease 2019 (COVID-19) outbreak in China: Summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA 323: 1239-1242. 2. Chen N, Zhou M, Dong X, Qu J, Gong F, et al. (2020) Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan,
Load more

Recommended publications
  • Letters to the Editor
    letters to the Editor Porphyria, Cardiopulmonary Bypass, and heart with additional hemorrhage into the pericardial sac (5). Peri- cardiocentesis, however, can be a temporizing measure in the se- Volatile Anesthetics verely compromised patient (4,7,8) until definitive surgical estab- lishment of a pericardial window. A pericardial window can be To the Editor: established under local anesthesia (9) via the subxiphoid or lateral We take issue with Stevens et al’s contentious statements in their thoracotomy approach (1,2,5,8,9). The subxiphoid approach is less discussion of volatile anesthetics in the patient with acute intermit- useful for trauma because limited surgical exposure may preclude tent porphyria undergoing mitral valve replacement (1). repair of cardiac wounds (2). However, a pericardial window dur- In the “pre-propofol” era, the safe and appropriate use of halo- ing awake lateral thoracotomy may be both poorly tolerated and thane and isoflurane in porphyric patients was established (2). dangerous in the distressed, moving patient (7). Recent reports of the successful use of isoflurane in porphyric A blunt trauma victim (2) recently presented for an emergent patients undergoing cardiac surgery also exist (3,4). As the authors surgical pericardial window for recurrent acute pericardial tampon- themselves allude to a report of elevated porphyrins after propofol ade. Although the patient was not hypotensive, jugular venous anesthesia in acute intermittent porphyria, favoring propofol over distention, pulsus paradoxus (1,3,7), patient distress (4), and echo- inhaled anesthetics because of the latter’s implied lack of a “safety cardiographic signs were present. As an alternative to endotracheal record” cannot be supported.
    [Show full text]
  • Icd-9-Cm (2010)
    ICD-9-CM (2010) PROCEDURE CODE LONG DESCRIPTION SHORT DESCRIPTION 0001 Therapeutic ultrasound of vessels of head and neck Ther ult head & neck ves 0002 Therapeutic ultrasound of heart Ther ultrasound of heart 0003 Therapeutic ultrasound of peripheral vascular vessels Ther ult peripheral ves 0009 Other therapeutic ultrasound Other therapeutic ultsnd 0010 Implantation of chemotherapeutic agent Implant chemothera agent 0011 Infusion of drotrecogin alfa (activated) Infus drotrecogin alfa 0012 Administration of inhaled nitric oxide Adm inhal nitric oxide 0013 Injection or infusion of nesiritide Inject/infus nesiritide 0014 Injection or infusion of oxazolidinone class of antibiotics Injection oxazolidinone 0015 High-dose infusion interleukin-2 [IL-2] High-dose infusion IL-2 0016 Pressurized treatment of venous bypass graft [conduit] with pharmaceutical substance Pressurized treat graft 0017 Infusion of vasopressor agent Infusion of vasopressor 0018 Infusion of immunosuppressive antibody therapy Infus immunosup antibody 0019 Disruption of blood brain barrier via infusion [BBBD] BBBD via infusion 0021 Intravascular imaging of extracranial cerebral vessels IVUS extracran cereb ves 0022 Intravascular imaging of intrathoracic vessels IVUS intrathoracic ves 0023 Intravascular imaging of peripheral vessels IVUS peripheral vessels 0024 Intravascular imaging of coronary vessels IVUS coronary vessels 0025 Intravascular imaging of renal vessels IVUS renal vessels 0028 Intravascular imaging, other specified vessel(s) Intravascul imaging NEC 0029 Intravascular
    [Show full text]
  • Xellia Pharmaceuticals, Aps Advisory Committee Background Document
    BACITRACIN for Injection (bacitracin) Advisory Committee Background Document Staphylococcal pneumonia and empyema in infants Xellia Pharmaceuticals, ApS Advisory Committee Background Document Meeting of the Antimicrobial Drugs Advisory Committee (AMDAC) on Safety and Efficacy of Bacitracin for Intramuscular Injection BACITRACIN for Injection (bacitracin) AVAILABLE FOR PUBLIC DISCLOSURE WITHOUT REDACTION Issue/Report Date: 28 March 2019 Approved date: 27 March 2019 Page 1 of 52 BACITRACIN for Injection (bacitracin) Advisory Committee Background Document Staphylococcal pneumonia and empyema in infants Table of Contents 1 EXECUTIVE SUMMARY ............................................................................................................5 2 Introduction .....................................................................................................................................7 3 Clinical data on effectiveness of bacitracin for injection ................................................................8 3.1 Approved Indication: Staphylococcal Pneumonia and Empyema in Infants ........................... 8 3.1.1 Supporting data on the treatment of lung infections in adults ........................................... 9 3.1.2 Data on intrapleural administration in infants and children with empyema ...................... 9 3.2 Alternate uses for Bacitracin for injection .............................................................................. 10 3.2.1 Surgical Site Infection (SSI) Prophylaxis .......................................................................
    [Show full text]
  • Pneumopericardium and Pneumomediastinum Complicating Endotracheal Intubation D
    Postgraduate Medical Journal (April 1979) 55, 273-275 Postgrad Med J: first published as 10.1136/pgmj.55.642.273 on 1 April 1979. Downloaded from Pneumopericardium and pneumomediastinum complicating endotracheal intubation D. O'NEILL D. N. K. SYMON M.B., Ch.B., M.R.C.P. B.Sc., M.B., Ch.B., M.R.C.P. Department of Cardiology, Western Infirmary, Glasgow GIl 6NT Summary was promptly inserted by the house physician. This Pneumopericardium and pneumomediastinum have type of tube has a total length of 30 cm with mark- been described as complications of endotracheal ings at 22, 24 and 26 cm. It was not trimmed before intubation and assisted ventilation in neonates and insertion. Copious secretions were aspirated and children. Here the occurrence of these complications intermittent positive pressure ventilation commenced in an adult is described and the possible mechanism using an Ambu bag. It was then noticed that the discussed. left lung was not being inflated and the tube was partially withdrawn. Ventilation with the Ambu bag Introduction was continued for 30 minutes until spontaneous The use of the endotracheal tube during surgery ventilation returned. During this period gastric has become the most widely used and acceptable lavage was carried out after an oro-gastric tube had method of providing an airway and of assisting in been passed without difficulty. Protected by copyright. the ventilation of the patient. Although some On admission to the intensive care unit he was complications do arise, the beneficial aspects of the noted to have a loud pericardial friction rub audible procedure have far outweighed the limitations due to over the entire praecordium.
    [Show full text]
  • IAO International Archives of Otorhinolaryngology
    International Archives of IAO Otorhinolaryngology ProfOrganizing. Ricardo Committee F erreira Bento Virtual Congress of theHe Otorhinolaryngologyaring & Balanc Foundatione 2017 PreProf.sident Dr. Richard Louis Voegels DrProf.. RDr.obinson Ricardo Ferreira Koji Bento Tsu ji President of Scientific Comission Dra. Ana Carolina Fonseca General Secretary 2020 OFFICIAL PROGRAM ABSTRACTS CCALLALL FFOROR PPAPERSAPERS YYouou areare invitedinvited to to submit submi tthe th efull ful articlesl article presenteds presente atd at VirVirtualth Congress Congress of Otorhinolaryngology of Otorhinolaryngology Foundation Foundation free free of of cost to thethe InternationalInternational ArchiArchivesves ofof OtorhinolaryngologyOtorhinolaryngology.. IAO is an international peer-reviewed journal focusing on disorders of the ear, nose, mouth, pharynx, larynx, cervical region, upper airway system, audiology and communication disorders. Published quarterly, the journal covers the entire spectrum of otorhinolaryngology – from prevention, to diagnosis, treatment and rehabilitation. ISSN 1809–9777 International Archives of IAO Otorhinolaryngology Editor in Chief Issue 3 • Volume 24 • July – August – September 2020 Why publish in IAO? Geraldo Pereira Jotz Co-Editor Aline Gomes Bittencourt • Rigorous Peer-Review by Leading Specialists. • International Editorial Board. • Continuous Publication: Speeding up the Publication of Articles. • Web-based Manuscript Submission. • Complete Free Online Access to all Published Articles via Thieme E-Journals at www.thieme-connect.com/products
    [Show full text]
  • Cardiac Tamponade Caused by Pericardial Effusion in a Patient with Systemic Capillary Leak Syndrome
    Netherlands Journal of Critical Care Submitted July 2017; Accepted November 2017 CASE REPORT Cardiac tamponade caused by pericardial effusion in a patient with systemic capillary leak syndrome W.L. Zoetman1, J.E. Paramarta2, C. Bouman1, B.T. Sanou3, A.P.J. Vlaar1,2 Departments of 1Intensive Care Medicine, 2Internal Medicine and 3Anaesthesiology, Academic Medical Center, Amsterdam, the Netherlands Correspondence A.P.J. Vlaar - [email protected] Keywords - intensive care, critically ill, capillary leakage, shock, tamponade Abstract We present a patient with systemic capillary leak syndrome show any abnormalities, in particular no abnormal haemoglobin (SCLS), complicated by obstructive shock due to cardiac phenotyping. No treatment was initiated, follow-up of the tamponade. anaemia was performed in the outpatient clinic. Methods: SCLS is a rare disease characterised by hypotension, hypoalbuminaemia, haemoconcentration and generalised Table 1. Laboratory values illustrating the course of SCLS oedema. Several severe complications have been described, Laboratory test Out-patient ER ICU admis- ICU day 1 ICU day 2 clinic sion including acute kidney injury, rhabdomyolysis, compartment Haemoglobin (g/dL, 12.4 20.9 16.3 14.8 11.1 syndrome and death. We present a patient with SCLS, 13.7-16.9) complicated by rapidly progressive pericardial effusion with Haematocrit (L/L, 0.38 0.62 - - 0.32 cardiac tamponade, for which a lifesaving pericardiocentesis 0.35-0.4) was performed. Because SCLS is often confused with septic Creatinine (µmol/L, 52 118 172 175 169 shock and anaphylactic shock, an obstructive shock may be 65-95) easily missed. Albumin (g/L, 44 - <10 27 28 35-50) Although SCLS is a very rare disorder, it is important to be aware Creatinine kinase 264 149 44377 81622 of its existence and the possible life-threatening complications, (U/L) including cardiac tamponade, in order to improve the outcome for the patient.
    [Show full text]
  • Esophagogastric Tamponade Tube
    Unit IV Gastrointestinal System Section Sixteen Special Gastrointestinal Procedures PROCEDURE Esophagogastric 108 Tamponade Tube Rosemary Lee PURPOSE: Esophagogastric tamponade therapy is used to provide temporary control of bleeding from gastric or esophageal varices. • Contraindications include latex allergy, esophageal strictures, PREREQUISITE NURSING and recent esophageal surgery. Relative contraindications are KNOWLEDGE heart failure, respiratory failure, hiatal hernia, severe pulmo- nary hypertension, and cardiac dysrhythmias. 4,8,12 • Tamponade therapy exerts direct pressure against the • Because of the risk for aspiration, it is recommended the varices with the use of a gastric and/or esophageal balloon patient be endotracheally intubated for airway protection and may be used for patients who are unresponsive to before esophagogastric tamponade tube insertion. 13 medical therapy or are too hemodynamically unstable for • Sedation should be considered, but dosing should be indi- endoscopy or sclerotherapy. 1,3 vidualized on the assessment of each patient. Sedation • Esophagogastric tamponade tubes are used to control should be used with caution in the setting of liver injury bleeding from either gastric and/or esophageal varices. and/or failure due to these patients ’ impaired metabolism The suction lumens allow the evacuation of accumulated of sedating medications. The plan for sedation, if needed, blood from the stomach or esophagus. The suction lumens is individualized with the goal to achieve patient comfort. also allow for the intermittent instillation of saline solu- • Head of bed (HOB) should be at least 30 to 45 degrees at tion to assist with evacuation of blood or clots and provide all times to reduce the risk of aspiration. 6 a means of irrigation if indicated.
    [Show full text]
  • Zaporozhye State Medical University OTORHINOLARYNGOLOGY the SELF-STUDY TUTORIAL for English Medical Students НАВЧАЛЬНО
    Zaporozhye State Medical University OTORHINOLARYNGOLOGY THE SELF-STUDY TUTORIAL for english medical students НАВЧАЛЬНО-МЕТОДИЧНИЙ ПОСІБНИК з оториноларингології для самостійної роботи студентів вищих медичних навчальних закладів з англійською формою навчання Department of Otorhinolaryngology 2012 Автори співробітнки кафедри оториноларингології Запорізького державного медичного університета: професор В.І.Троян, доцент І.М.Нікулін, доцент М.І.Нікулін, асистент О.М. Костровський Рецензенти: Бердюк І.В. – д.мед.н., професор кафедри стоматології ЗДМУ Волкова Г.К. – к.пед.н., доцент кафедри іноземних мов ЗДМУ Затверждено на засіданні ЦМР Запорізького державного медичного університета «____» ______________2012г. Preface The speciality of Ear,Nose and Throat,now better known as Otolaryngology:Head and Neck Surgery, stands at cross-roads with several other specialities and subspecialities such as neurology,neurosurgery,oncologic surgery,ophthalmology,paediatrics,plastic and reconstructive surgery,respiratory medicine and critical care,gastroenterology,allergy and immunology.The boundaries between these specialities and ours are indistinct and frequently transgressed.This has also led to the development of several subspecialities(better called superspicialities) within Otolaryngology thus giving birth to Otology, Otoneurology,Paediatric Otolaryngology,Skull Base Surgery,Head and Neck Oncology,Endoscopic and Minimal Access Surgery,Laryngology and Phonosurgery.With advances in technology such as advace computer imaging techniques with 3D reconstructions,endoscopes,powered instrumentation, navigational surgery,lasers,intensity modulated radiotherapy,stereotactic radiosurgery,etc.patient care has greatly improved.This has also put a greater demand on new generations of medical students who should be introduced to these advancements. I. STUDY PLAN H o u r s Audience Cinds STRUCTURE Altogether / Course Practical USW control credits Lecture lessons Modulus 1 90/3 Initial, 10 40 40 4 Modulus 3 Credit ECTS boundary 90/3 Initial, Altogether Credit ECTS 10 40 40 4 boundary II.
    [Show full text]
  • PDF in English
    Review Article Perforation of Nasal Septum: Etiology and Diagnosis Perfuração do Septo Nasal: Etiologia e Diagnóstico Marco Aurélio Fornazieri*, Jemima Herrero Moreira**, Renata Pilan***, Richard Louis Voegels****. * ENT. ** Fellowship in Endonasal Endoscopic Surgery and Facial Plastic Surgery. ENT. *** Endonasal Endoscopic Surgery Fellowship in the Division of Clinical Otorhinolaryngology, HC / FMUSP. Otolaryngologists. **** Associate Professor, Division of Clinical Otorhinolaryngology, Hospital of the Faculty of Medicine, University of São Paulo. Institution: Faculty of Medicine, University of São Paulo. São Paulo / SP - Brazil. Mail Address: Department of Otolaryngology, School of Medicine, USP - Avenida Dr. Eneas de Carvalho Aguiar, 255 - 6th Floor - Room 6167 - São Paulo / SP - Brazil - Zip code: 05403-000 - Telephone / Fax: (+55 11) 3088-0299 - E-mail: [email protected] Article received on May 13, 2009. Approved on August 10, 2009. SUMMARY Introduction: The nasal septum perforation is an occasional finding of rhinoscopy and most patients are asymptomatic. However, there are several possible etiologies of this condition, making necessary a thorough investigation. Objective: To review the literature the main causes of septal perforation and describe the diagnostic tests currently used. Method: A systematic literature review of journals indexed identifiable until December 2008. Final Comments: The main causes are the traumatic / iatrogenic nasal drug use, exposure to toxic gases, inflammatory and infectious diseases and neoplasms. The diagnosis is based on detailed medical history, focusing on occupation and origin of the patient, observation of the characteristics of mucosal injury on biopsy and collection of additional tests such as ANCA, guided by the main suspect. Keywords: nasal septum, diagnosis, granuloma. RESUMO Introdução: A perfuração do septo nasal é um achado ocasional da rinoscopia anterior e a maioria dos pacientes são assintomáticos.
    [Show full text]
  • Effect of Posterior Pericardial Drainage on the Incidence of Pericardial Effusion After Ascending Aortic Surgery
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE Eryilmaz et al Surgery for Acquired Cardiovascular Disease provided by Elsevier - Publisher Connector Effect of posterior pericardial drainage on the incidence of pericardial effusion after ascending aortic surgery Sadik Eryilmaz, MD, Ozan Emiroglu, MD, Zeynep Eyileten, MD, Ruchan Akar, MD, Levent Yazicioglu, MD, Refik Tasoz, MD, Bulent Kaya, MD, Adnan Uysalel, MD, Kemalettin Ucanok, MD, Tumer Corapcioglu, MD, and Umit Ozyurda, MD ACD Objective: Pericardial effusion and cardiac tamponade after ascending aortic surgery are higher than anticipated after cardiac surgery. We evaluated a thin closed-suction drain system to prevent posterior pericardial effusion in patients undergoing ascend- ing aortic surgery. Methods: One hundred forty patients who underwent ascending aortic surgery were prospectively randomized into group A and group B. In group A (n ϭ 70) we used a 32F drain placed anteriorly overlying the heart and a 16F thin drain placed retrocardially. In group B (n ϭ 70) only a 32F drain placed anteriorly was used. In group A we removed the large drain on the first postoperative day and continued drainage with the thin drain until the drainage was less than 50 mL in a 24-hour period. In group B we removed the drain after the first postoperative day when the drainage was less than 50 mL in an 8-hour period. Preoperative, perioperative, and postoperative parameters of the patients were compared. Results: No significant posterior pericardial effusion and late cardiac tamponade developed in patients in group A. In group B 10 (14.3%) patients experienced significant posterior pericardial effusion and 4 (5.7%) patients experienced late cardiac tamponade; the incidence of significant pericardial effusion in group B was significantly higher (P ϭ .001).
    [Show full text]
  • Diagnosis and Management of Pericardial Effusion
    Journal of Mind and Medical Sciences Volume 7 Issue 2 Article 4 2020 Diagnosis and management of pericardial effusion Maria Manea UNIVERSITY EMERGENCY CENTRAL MILITARY HOSPITAL, CARDIOLOGY CLINIC, BUCHAREST, ROMANIA Ovidiu Gabriel Bratu CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY, DEPARTMENT OF UROLOGY, UNIVERSITY EMERGENCY CENTRAL MILITARY HOSPITAL, ACADEMY OF ROMANIAN SCIENTISTS, BUCHAREST, ROMANIA Nicolae Bacalbasa CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY, DEPARTMENT OF VISCERAL SURGERY, FUNDENI CLINICAL INSTITUTE, BUCHAREST, ROMANIA Camelia Cristina Diaconu CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY, DEPARTMENT OF INTERNAL MEDICINE, CLINICAL EMERGENCY HOSPITAL OF BUCHAREST, BUCHAREST, ROMANIA Follow this and additional works at: https://scholar.valpo.edu/jmms Part of the Cardiology Commons, and the Critical Care Commons Recommended Citation Manea, Maria; Bratu, Ovidiu Gabriel; Bacalbasa, Nicolae; and Diaconu, Camelia Cristina (2020) "Diagnosis and management of pericardial effusion," Journal of Mind and Medical Sciences: Vol. 7 : Iss. 2 , Article 4. DOI: 10.22543/7674.72.P148155 Available at: https://scholar.valpo.edu/jmms/vol7/iss2/4 This Review Article is brought to you for free and open access by ValpoScholar. It has been accepted for inclusion in Journal of Mind and Medical Sciences by an authorized administrator of ValpoScholar. For more information, please contact a ValpoScholar staff member at [email protected]. Journal of Mind and Medical Sciences https://scholar.valpo.edu/jmms/ https://proscholar.org/jmms/
    [Show full text]
  • Introduction Optimizing Outcomes In
    Approved by the AUA Board of Directors October 2018 © 2018 by the American Urological Association Optimizing Outcomes in Urologic Surgery: Postoperative Angela Smith, MD, MS, FACS (Chair), Megan Anders, MD, Gregory Auffenberg, MD, Siamak Daneshmand, MD, Chad Elllimootil, MD, Jane Fellows, MSN, CWOCN, Scott Gilbert, MD, John L. Gore, MD, Suzanne Merrill, MD, Kenneth Nepple, MD, Leanne Richbourg, MSN, APRN-BC, CWON-AP, CCCN, GCNS-BC, Charlene Vollmer, BSN, RN-BC The American Urological Association gratefully acknowledges the assistance of the American Society of Anesthesiologists and Society of Urologic Nurses and Associates in the creation of the white paper. Introduction Understanding best practices in perioperative care is critical for quality of care for our urologic patients. In the third part of this white paper series, we provide a summary of key elements to optimize postoperative care in adult urologic surgery. Optimal postoperative care includes minimizing postoperative complications, optimizing postoperative recovery and improving patients’ postsurgical outcomes. The assembled white paper multidisciplinary writing team includes experts in a number of different areas (urologists, nurses, anesthesiologists) to address a comprehensive set of topics that urologic providers face when caring for postoperative patients. The importance of improving postoperative care has grown out of the Enhanced Recovery after Surgery (ERAS) movement, which emphasizes the importance of standardizing elements of postoperative care. Lessons learned from ERAS protocols suggest that compiling and using the best evidence-based medicine can improve the surgical outcomes of our patients. However, assembling these resources is challenging, and we recognized a distinct need from our membership to compile a single, concise resource that provides this information in one place.
    [Show full text]